A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State
Clinical trial NCT04451772 · COMPLETED
Trial details
- NCT number
- NCT04451772
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2024-01-03
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.